Stenting and Resection for Stage IV Colorectal Cancer Endoscopic Stenting and Colorectal Resection in Stage IV
Patients with Stage IV obstructing colorectal cancer and unresectable liver metastses, with general and local conditions not a risk for coliorectal resection, will be randomized to have either endoscopic stenting or colorectal resection
Colorectal Neoplasm
PROCEDURE: ENDOSCOPIC PLACEMENT OF EXPANDABLE STENT
MORTALITY, THE NUMBER OF POSTPROCEDURAL DEATHS, 60 DAYS|SURVIVAL, SURVIVAL IN MONGTHS WILL BE DETERMINED FOR PATIENTS USING KAPLAN MEIER CURVES AND MEDIAN SURVIVAL, 5 YEARS|POSTOPERATIVE MORBIDITY, MAJOR AND MINOR COMPLICATIONS AFTER THE PROCEDURE, 60 DAYS
QUALITY OF LIFE, QUALITY OF LIFE WILL BE ASSESSED USING A STANDARDIZED PROTOCOL, 5 YEARS
Patients with obstructing colorectal cancer, Stage IV with not resectable metastases will be considered .

Patients with acceptable general and local conditions, to allow a safe surgical resection will be considered.

Patients will be randomized to have endoscopic stenting or colorectal resection.

All patients will receive postoperative chemio therapy